Family · Pharmaceutical analytical standards
Abemaciclib
An inhibitor of the CDK4 and CDK6 kinases, approved in the United States in 2017 for advanced hormone receptor-positive, HER2-negative breast cancer, both on its own and together with hormone therapy. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?The suffix -ciclib, shared with palbociclib and ribociclib, marks inhibitors of cyclin-dependent kinases, the proteins that give the cell the go-ahead to divide.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
